מיפג'ין

Država: Izrael

Jezik: hebrejščina

Source: Ministry of Health

Aktivna sestavina:

MIFEPRISTONE

Dostopno od:

A. LAPIDOT PHARMACEUTICALS, LTD

Koda artikla:

G03XB01

Farmacevtska oblika:

טבליה

Sestava:

MIFEPRISTONE 200 MG

Pot uporabe:

פומי

Tip zastaranja:

מרשם נדרש

Izdeluje:

EXELGYNE LABORATORIES, FRANCE

Terapevtska skupina:

MIFEPRISTONE

Terapevtsko območje:

MIFEPRISTONE

Terapevtske indikacije:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

Datum dovoljenje:

2014-07-31